NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) stock
Close on Nov 17, 2026Market cap $6.43MP/E –Yield –
Earnings
Neuroone Medical Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Neuroone Medical Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q1 FY2027ended Dec 31, 2026 | Feb 16, 2027Expected | – | – | – | – |
| Q4 FY2026ended Sep 30, 2026 | Oct 5, 2026before the open | $3.80M | +40.7% | – | Release |
| Q3 FY2026ended Jun 30, 2026 | Aug 13, 2026before the open | $2.00M | +17.6% | -$0.28 | Release |
| Q2 FY2026ended Mar 31, 2026 | May 12, 2026before the open | $2.40M | +71.4% | -$0.25 | Release |
| Q1 FY2026ended Dec 31, 2025 | Feb 17, 2026before the open | $2.90M | -53.2% | – | Release |
| Q4 FY2025ended Sep 30, 2025 | Dec 17, 2025before the open | $2.70M | +800.0% | -$0.03 | Release |
| Q3 FY2025ended Jun 30, 2025 | Aug 14, 2025before the open | $1.70M | – | -$0.03 | Release |
| Q2 FY2025ended Mar 31, 2025 | May 13, 2025before the open | $1.40M | +1.7% | -$0.07 | Release |
| Q1 FY2025ended Dec 31, 2024 | Jan 10, 2025before the open | $6.20M | +533.9% | – | Release |
| Q4 FY2024ended Sep 30, 2024 | Dec 17, 2024before the open | $300.00K | -59.6% | – | Release |
| Q3 FY2024ended Jun 30, 2024 | Aug 14, 2024after the close | – | – | -$0.10 | Release |
| Q2 FY2024ended Mar 31, 2024 | May 14, 2024after the close | $1.38M | +195.5% | -$0.11 | Release |
| Q1 FY2024ended Dec 31, 2023 | Feb 13, 2024after the close | $978.00K | – | -$0.14 | Release |
| Q4 FY2023ended Sep 30, 2023 | Dec 14, 2023after the close | $742.00K | – | – | Release |
| Q3 FY2023ended Jun 30, 2023 | Aug 14, 2023after the close | – | – | -$0.20 | Release |
| Q2 FY2023ended Mar 31, 2023 | May 11, 2023after the close | $466.00K | +1159.5% | -$0.21 | Release |
| Q1 FY2023ended Dec 31, 2022 | Feb 14, 2023after the close | – | – | -$0.11 | Release |
| Q4 FY2022ended Sep 30, 2022 | Dec 22, 2022before the open | – | – | – | Release |
| Q3 FY2022ended Jun 30, 2022 | Aug 11, 2022after the close | $32.00K | – | – | Release |
| Q2 FY2022ended Mar 31, 2022 | May 12, 2022after the close | $37.00K | – | – | Release |
| Q1 FY2022ended Dec 31, 2021 | Feb 14, 2022after the close | – | – | – | Release |
| Q4 FY2021ended Sep 30, 2021 | Dec 15, 2021before the open | – | – | – | Release |
| Q3 FY2021ended Jun 30, 2021 | Aug 13, 2021before the open | – | – | – | Filing |
| Q2 FY2017ended Jun 30, 2017 | Aug 14, 2017after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Neuroone Medical Technologies guided for has been reported
Guidance vs results
The last range Neuroone Medical Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Revenue | $9.20M – $10.50M | $11.10MΣ4Q | Above range |
| FY2026 | Revenue growth | +17% | -7.5%Σ4Q | Below range |
| FY2025 | Revenue | $8.00M – $10.00M | $12.00MΣ4Q | Above range |
Guidance history
Every forecast Neuroone Medical Technologies put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 13, 2026 | Recognized revenue | FY2026 | $9.20M – $10.50M | Lowered |
| Feb 17, 2026 | product revenue increase | FY2026 | +17% | New |
| Feb 17, 2026 | product revenue | FY2026 | $10.50M | New |
| Aug 14, 2025 | product gross margin | FY2025 | 50% – 53% | New |
| Aug 14, 2025 | product revenue | FY2025 | $8.00M – $10.00M | New |
| May 13, 2025 | product gross margin | FY2025 | 47% – 51% | Reaffirmed |
| May 13, 2025 | product revenue increase | FY2025 | +132% – +190% | New |
| May 13, 2025 | product revenue | FY2025 | $8.00M – $10.00M | Reaffirmed |
| Jan 10, 2025 | product gross margin | FY2025 | 47% – 51% | Reaffirmed |
| Jan 10, 2025 | product revenues | FY2025 | $8.00M – $10.00M | Reaffirmed |
| Dec 17, 2024 | product gross margin | FY2025 | 47% – 51% | New |
| Dec 17, 2024 | product revenue | FY2025 | $8.00M – $10.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Neuroone Medical Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- Update
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- News
See a number that looks wrong?